Lista de obras - Arantxa Gonzalez - Dominio Público Uruguay

A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population

artículo científico publicado en 2017

Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan

scientific journal article

Alteraciones del metabolismo del colágeno fibrilar en la cardiopatía hipertensiva. Situación actual y perspectivas

artículo científico publicado en 2006

Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure.

artículo científico publicado en 2013

Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.

artículo científico publicado en 2016

Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study

scientific article published on 27 May 2019

Biochemical Assessment of Myocardial Fibrosis in Hypertensive Heart Disease ⬇️

artículo científico publicado el 1 de noviembre de 2001

Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.

artículo científico publicado en 2012

Bone marrow cells adopt the cardiomyogenic fate in vivo

artículo científico publicado en 2007

CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation

scientific article published on 01 March 2019

Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

scientific article published in 2023

Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload

scientific article published on 01 April 2019

Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?

scientific article published on 13 January 2020

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy

artículo científico publicado en 2010

Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling

artículo científico publicado en 2017

Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload

artículo científico publicado en 2019

Circulating Biomarkers Predicting Longitudinal Changes in Left Ventricular Structure and Function in a General Population

artículo científico publicado en 2019

Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.

artículo científico

Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease

artículo científico publicado en 2019

Clinical aspects of hypertensive myocardial fibrosis ⬇️

artículo científico publicado el 1 de noviembre de 2001

Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation

scientific article published on 01 April 2019

Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis.

artículo científico publicado en 2013

Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population.

artículo científico publicado en 2016

Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGi

scientific article published on 16 January 2020

Formation of large coronary arteries by cardiac progenitor cells

artículo científico publicado en 2008

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology

artículo científico publicado en 2018

Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.

scientific article published on January 2011

Identification of a coronary vascular progenitor cell in the human heart

artículo científico publicado en 2009

Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis

artículo científico publicado en 2018

Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction.

artículo científico publicado en 2017

Increased fibroblast growth factor 23 in heart failure: Biomarker, mechanism or both?

artículo científico publicado en 2019

Involvement of cardiomyocyte survival–apoptosis balance in hypertensive cardiac remodeling

artículo científico publicado en 2003

Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

artículo científico publicado en 2005

Is the deficiency of the long isoform of cellular FLICE-inhibitory protein involved in myocardial remodeling?

artículo científico publicado en 2010

Is the tissue availability of circulating insulin-like growth factor I involved in organ damage and glucose regulation in hypertension? ⬇️

artículo científico publicado el 1 de octubre de 1997

Mechanisms of Increased Susceptibility to Angiotensin II–Induced Apoptosis in Ventricular Cardiomyocytes of Spontaneously Hypertensive Rats

scientific article published on 01 December 2000

Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.

artículo científico publicado en 2017

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

artículo científico publicado en 2017

Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure

artículo científico publicado en 2016

Myocardial Remodeling in Hypertension

artículo científico publicado en 2018

Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model

article

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

artículo científico publicado en 2007

Myocardial fibrosis: biomedical research from bench to bedside.

artículo científico publicado en 2017

Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment

scientific article published on 20 November 2019

Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction

artículo científico publicado en 2020

Notch1 regulates the fate of cardiac progenitor cells

artículo científico publicado en 2008

Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation

artículo científico publicado en 2017

Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?

artículo científico publicado en 2013

Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

artículo científico publicado en 2017

Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses

scientific article published on 06 May 2019

Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients.

artículo científico publicado en 2016

Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure

scientific article published on 18 August 2018

Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure

scientific article published on 01 May 2019

Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients.

artículo científico publicado en 2017

Reply: Aortic Stenosis, Left Ventricular Remodeling, and Renin-Angiotensin System Blockade

scientific article published on 01 June 2018

Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis.

artículo científico publicado en 2018

ST2 in Heart Failure

artículo científico publicado en 2018

The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives.

artículo científico publicado en 2003

The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes

artículo científico publicado en 2016

The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking

scientific article published on 08 June 2019

The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

artículo científico publicado en 2017

The renal immune-inflammatory component of arterial hypertension: Emerging therapeutic strategies

artículo científico publicado en 2019

The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction

artículo científico publicado en 2016

Understanding the Role of CCN Matricellular Proteins in Myocardial Fibrosis ∗

artículo científico publicado en 2016

Unraveling New Mechanisms of Renal Fibrosis With Potential Therapeutic Implications

artículo científico publicado en 2018

Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction

artículo científico publicado en 2007

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

artículo científico publicado en 2024

Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction

artículo científico publicado en 2017

Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients

artículo científico publicado en 2005

[Vascular oxidative stress and endothelial dysfunction]

artículo científico publicado en 2001

microRNA-122down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1up-regulation

artículo científico publicado en 2014

p-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling.

artículo científico publicado en 2015

Lista de obras de Arantxa Gonzalez

A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population

Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan

Alteraciones del metabolismo del colágeno fibrilar en la cardiopatía hipertensiva. Situación actual y perspectivas

Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure.

Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.

Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study

Biochemical Assessment of Myocardial Fibrosis in Hypertensive Heart Disease ⬇️

Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.

Bone marrow cells adopt the cardiomyogenic fate in vivo

CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation

Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload

Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy

Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling

Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload

Circulating Biomarkers Predicting Longitudinal Changes in Left Ventricular Structure and Function in a General Population

Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.

Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease

Clinical aspects of hypertensive myocardial fibrosis ⬇️

Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation

Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis.

Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population.

Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGi

Formation of large coronary arteries by cardiac progenitor cells

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology

Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.

Identification of a coronary vascular progenitor cell in the human heart

Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis

Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction.

Increased fibroblast growth factor 23 in heart failure: Biomarker, mechanism or both?

Involvement of cardiomyocyte survival–apoptosis balance in hypertensive cardiac remodeling

Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

Is the deficiency of the long isoform of cellular FLICE-inhibitory protein involved in myocardial remodeling?

Is the tissue availability of circulating insulin-like growth factor I involved in organ damage and glucose regulation in hypertension? ⬇️

Mechanisms of Increased Susceptibility to Angiotensin II–Induced Apoptosis in Ventricular Cardiomyocytes of Spontaneously Hypertensive Rats

Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure

Myocardial Remodeling in Hypertension

Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

Myocardial fibrosis: biomedical research from bench to bedside.

Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment

Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction

Notch1 regulates the fate of cardiac progenitor cells

Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation

Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?

Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses

Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients.

Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure

Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure

Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients.

Reply: Aortic Stenosis, Left Ventricular Remodeling, and Renin-Angiotensin System Blockade

Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis.

ST2 in Heart Failure

The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives.

The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes

The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking

The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

The renal immune-inflammatory component of arterial hypertension: Emerging therapeutic strategies

The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction

Understanding the Role of CCN Matricellular Proteins in Myocardial Fibrosis ∗

Unraveling New Mechanisms of Renal Fibrosis With Potential Therapeutic Implications

Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction

Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients

[Vascular oxidative stress and endothelial dysfunction]

microRNA-122down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1up-regulation

p-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling.